SHILPA MEDICARE LTD. SHARE PRICE [LIVE]

BSE: INE790G01031   NSE: SHILPAMED   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
397.00
Change:
BSE
397.30
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in SHILPA MEDICARE LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

SHILPAMED News

Frequently Asked Questions

What is the Share price of SHILPA MEDICARE LTD. (SHILPAMED)?

SHILPA MEDICARE LTD. (SHILPAMED) share price as of August 12, 2022, on NSE is Rs 397.00 (NSE) and Rs 397.30 (BSE) on BSE.

Can I buy SHILPA MEDICARE LTD. (SHILPAMED) shares?

Yes, You can buy SHILPA MEDICARE LTD. (SHILPAMED) shares by opening a Demat account with Angel One.

How do I buy SHILPA MEDICARE LTD. (SHILPAMED) from Angel One?

SHILPA MEDICARE LTD. (SHILPAMED) share can be brought through the following modes:
  1. Direct investment: You can buy SHILPA MEDICARE LTD. (SHILPAMED) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to SHILPA MEDICARE LTD. (SHILPAMED) shares.

In which sector do SHILPA MEDICARE LTD. (SHILPAMED) belong?

SHILPA MEDICARE LTD. (SHILPAMED) belongs to Pharma.

About SHILPAMED

Today's live share price for SHILPA MEDICARE LTD. is NSE: ₹ 397.00, BSE: ₹ 397.30 with a current market capitalization of .

Shilpa Medicare Ltd., formerly known as Shilpa Antibiotics was incorporated as a private limited company in Nov.'87 and has been promoted by Vishnukant C Bhutada and his associates.The company produces trimethoprim, an anti-biotic bulk drug. It also manufactures the product for other reputed companies like Eskayef, Bombay Drugs & Pharmas, Bombay Drug House, US Vitamins, Sandoz India, etc, for their export commitments. Circa 1992, the company installed production facilities to manufacture sodium methoxide. SAL is the recipient of the World Health Organisation - Good Manufacturing Practices (GMP) certificate. It exports its products to hard-currency areas. The company manufactures 1-methyl, amino-1-methyl, thio-2-nitro ethane, a drug intermediate used in the manufacture of ranitidine, an anti-ulcer drug. The company proposes to embark upon an expansion project which involves the addition of one more bulk drug to its existing product range -- norfloxacin -- and expand the production capacity of the existing products of the company -- sodium methoxide and trimethoprim.

Read more